Company Filing History:
Years Active: 2023
Title: Anke Huber: Innovator in Adeno-Associated Viral Capsid Proteins
Introduction
Anke Huber is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of mutated adeno-associated viral capsid proteins. Her work has implications for drug delivery and gene therapy.
Latest Patents
Anke Huber holds a patent titled "Mutated adeno-associated viral capsid proteins for chemical coupling of ligands, nanoparticles or drugs via thioether binding and production method thereof." This invention focuses on a mutated adeno-associated virus (AAV) capsid protein, which includes a substitution of a wild type non-cysteine amino acid into a cysteine. This modification allows for specific binding reactions, enhancing the potential for targeted therapies.
Career Highlights
Anke Huber is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V., a leading research organization in Germany. Her work at this institution has allowed her to explore innovative solutions in the field of gene therapy and biotechnology.
Collaborations
Anke Huber collaborates with Hildegard Büning, who is also a prominent figure in the field. Their partnership has contributed to advancements in the understanding and application of AAV technology.
Conclusion
Anke Huber's innovative work in the development of mutated adeno-associated viral capsid proteins showcases her commitment to advancing biotechnology. Her contributions are paving the way for new therapeutic approaches in medicine.